Monitoring Glucose Levels in Patients With Myocardial Infarction (COMGAMI)

Lars Ryden

Status: Terminated

Conditions: Hypoglycemia; Hyperglycemia; Acute Coronary Syndromes

Treatments: Device: OptiScanner®

Study type: Interventional

Funder types: Other

Identifiers

NCT03107806

2011/1446-31/1

Details and patient eligibility

About

To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes

Full description

Methodology Part a) Explorative Part b) Randomised, parallel-group design

Enrollment: 14 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Acute coronary syndrome according to the joint recommendations by the European Society of Cardiology (48, 49)
• Signed written informed consent consistent with Helsinki declaration and local legislations prior to participation in the trial.

Exclusion criteria

• <18 years old.
• Congestive heart failure.
• Patients who, in the opinion of the investigator, will have difficulties to comply with the protocol (examples: alcohol or drug abuse, psychiatric disorder).

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

14 participants in 2 patient groups

Glucose monitoring by OptiScanner®

Other group

Description:

Glucose monitoring and intervention guided by OptiScanner®

Treatment:

Device: OptiScanner®

Blinded continuous glucose monitoring

Other group

Description:

Blinded continuous glucose monitoring by OptiScanner® and glucose lowering intervention guided by routine glucose measurements

Treatment:

Device: OptiScanner®